name:-0.32818102836609
name:-0.20976495742798
name:-0.20094609260559
Ionis Pharmaceuticals, Inc. Patent Filings

Ionis Pharmaceuticals, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ionis Pharmaceuticals, Inc..The latest application filed is for "compounds and methods for modulating angiotensinogen expression".

Company Profile
200.200.200
  • Ionis Pharmaceuticals, Inc. - Carlsbad CA US
  • Ionis Pharmaceuticals, Inc. - Carisbad CA US
  • Ionis Pharmaceuticals, Inc. - Baltimore MD US
  • Ionis Pharmaceuticals, Inc. - San Diego CA US
  • Ionis Pharmaceuticals, Inc. - Encinitas CA US
  • IONIS PHARMACEUTICALS, INC. - Encintas CA US
  • Ionis Pharmaceuticals, Inc. - North Chicago IL US
  • Ionis Pharmaceuticals, Inc. - La Jolla CA US
  • Ionis Pharmaceuticals, Inc. - Solana Beach CA US
  • Ionis Pharmaceuticals, Inc. - Houston TX US
  • Ionis Pharmaceuticals, Inc. - Oceanside CA US
  • Ionis Pharmaceuticals, Inc. - Cardiff by the Sea CA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Compounds And Methods For Modulating Angiotensinogen Expression
App 20220298200 - Mullick; Adam ;   et al.
2022-09-22
Compounds and methods for modulating angiotensinogen expression
Grant 11,447,521 - Mullick , et al. September 20, 2
2022-09-20
Compounds And Methods For Reducing Spdef Expression
App 20220290137 - Freier; Susan M. ;   et al.
2022-09-15
2'-methoxy Substituted Oligomeric Compounds And Compositions For Use In Gene Modulations
App 20220288100 - Crooke; Stanley T.
2022-09-15
Compounds And Methods For Modulating Atxn1
App 20220290146 - Zhou; Keming
2022-09-15
Trans-cyclooctene Labeled Antisense Oligonucleotides, Radio Labeled Tetrazine And Methods
App 20220290140 - COOK; Brendon Ellery ;   et al.
2022-09-15
Compounds And Methods For Modulating Cln3 Expression
App 20220280545 - Hastings; Michelle L. ;   et al.
2022-09-08
Compounds and methods for reducing ATXN3 expression
Grant 11,434,488 - Freier September 6, 2
2022-09-06
Compositions And Methods For Modulating Ttr Expression
App 20220275365 - Prakash; Thazha P. ;   et al.
2022-09-01
Modulators Of Hsd17b13 Expression
App 20220273691 - Freier; Susan M. ;   et al.
2022-09-01
Modulation of Huntington expression
Grant 11,421,231 - Hung , et al. August 23, 2
2022-08-23
Compounds And Methods For Modulating Tmprss6 Expression
App 20220259600 - Guo; Shuling ;   et al.
2022-08-18
Modified CRISPR RNA and modified single CRISPR RNA and uses thereof
Grant 11,414,657 - Rahdar , et al. August 16, 2
2022-08-16
Synthesis Of Oligomeric Compounds Comprising Phosphorothioate Diester And Phosphodiester Linkages
App 20220251128 - McPherson; Andrew K. ;   et al.
2022-08-11
Methods And Compositions For Inhibiting Pmp22 Expression
App 20220251553 - Hung; Gene ;   et al.
2022-08-11
Modulators Of Irf4 Expression
App 20220241320 - ZHOU; Tianyuan ;   et al.
2022-08-04
Modulators Of Complement Factor B
App 20220243209 - Grossman; Tamar R. ;   et al.
2022-08-04
Modulators Of Malat1 Expression
App 20220243205 - FREIER; Susan M. ;   et al.
2022-08-04
Angiotensin Ii Type 1 Receptor Targeted Oligonucleotides And Uses Thereof
App 20220243210 - Mullick; Adam ;   et al.
2022-08-04
Compounds And Methods For Reducing Fus Expression
App 20220243203 - Bui; Huynh-Hoa
2022-08-04
Compositions And Methods For Modulating Tau Expression
App 20220243200 - Rigo; Frank
2022-08-04
Method of conjugating oligomeric compounds
Grant 11,400,161 - Cedillo , et al. August 2, 2
2022-08-02
Compositions and Methods for Modulating MECP2 Expression
App 20220226361 - Freier; Susan M.
2022-07-21
Modulation Of Apolipoprotein C-iii (apociii) Expression In Lipoprotein Lipase Deficient (lpld) Populations
App 20220213472 - Alexander; Veronica J. ;   et al.
2022-07-07
Modulation of factor 11 expression
Grant 11,376,273 - Freier , et al. July 5, 2
2022-07-05
Compounds And Methods For Reducing Atxn3 Expression
App 20220195431 - Zhao; Hien Thuy ;   et al.
2022-06-23
Compositions for Modulating Ataxin 2 Expression
App 20220195430 - Freier; Susan M.
2022-06-23
Modulators of EZH2 expression
Grant 11,365,416 - Jo , et al. June 21, 2
2022-06-21
Compositions And Methods For Enhanced Intestinal Absorption Of Conjugated Oligomeric Compounds
App 20220184112 - Searcy; Justin Drew ;   et al.
2022-06-16
Linkage Modified Oligomeric Compounds And Uses Thereof
App 20220186222 - Anderson; Brooke A. ;   et al.
2022-06-16
Compounds And Methods For Reducing Kcnt1 Expression
App 20220177893 - Bui; Huynh-Hoa ;   et al.
2022-06-09
Modulation Of Prekallikrein (pkk) Expression
App 20220170023 - Freier; Susan M. ;   et al.
2022-06-02
Methods For Reducing Ataxin-2 Expression
App 20220162615 - Rigo; Frank
2022-05-26
Compositions Comprising Alternating 2'-modified Nucleosides For Use In Gene Modulation
App 20220162603 - Allerson; Charles ;   et al.
2022-05-26
Compositions for modulating C9ORF72 expression
Grant 11,339,393 - Freier , et al. May 24, 2
2022-05-24
Compounds And Methods For Modulating Angiotensinogen Expression
App 20220153775 - Mullick; Adam ;   et al.
2022-05-19
Modified compounds and uses thereof
Grant 11,332,733 - Seth , et al. May 17, 2
2022-05-17
Compounds and methods for reducing LRRK2 expression
Grant 11,332,746 - Freier May 17, 2
2022-05-17
Methods Of Treating Breast Cancer
App 20220143066 - Spector; David L. ;   et al.
2022-05-12
Modulating apolipoprotein (a) expression
Grant 11,319,536 - Viney , et al. May 3, 2
2022-05-03
Modulators of diacyglycerol acyltransferase 2 (DGAT2)
Grant 11,312,962 - Bhanot , et al. April 26, 2
2022-04-26
Compositions and methods for modulating growth hormone receptor expression
Grant 11,312,964 - Prakash , et al. April 26, 2
2022-04-26
Modulation Of Gys1 Expression
App 20220112502 - Grossman; Tamar R. ;   et al.
2022-04-14
Compounds And Methods For Reducing Pmp22 Expression
App 20220112503 - Bui; Huynh-Hoa ;   et al.
2022-04-14
Conjugated antisense compounds and their use
Grant 11,299,736 - Prakash , et al. April 12, 2
2022-04-12
Compounds and methods for modulating SMN2
Grant 11,299,737 - Rigo April 12, 2
2022-04-12
Compositions and methods for modulating Ataxin 3 expression
Grant 11,293,025 - Rigo , et al. April 5, 2
2022-04-05
Modulators of MALAT1 expression
Grant 11,279,932 - Freier , et al. March 22, 2
2022-03-22
Compounds and Methods for Use in Dystrophin Transcript
App 20220081689 - Rigo; Frank ;   et al.
2022-03-17
Compositions And Methods For Treating And Preventing Amyotrophic Lateral Sclerosis
App 20220073930 - Nestorov; Ivan Alexandrov ;   et al.
2022-03-10
Compounds And Methods For Modulation Of Smn2
App 20220073914 - Rigo; Frank ;   et al.
2022-03-10
Methods And Compositions For Modulating Alpha-1-antitrypsin Expression
App 20220073913 - Monia; Brett P. ;   et al.
2022-03-10
5' modified nucleosides and oligomeric compounds prepared therefrom
Grant 11,268,094 - Prakash , et al. March 8, 2
2022-03-08
Compounds And Methods For Reducing Atxn3 Expression
App 20220064637 - Freier; Susan M.
2022-03-03
Modified Oligomeric Compounds And Uses Thereof
App 20220064636 - Seth; Punit P. ;   et al.
2022-03-03
Compounds and Methods for Reducing ATXN2 Expression
App 20220064639 - Freier; Susan M. ;   et al.
2022-03-03
Compounds And Methods For Modulating Smn2
App 20220064638 - Rigo; Frank ;   et al.
2022-03-03
Modulation Of Hepatitis B Virus (hbv) Expression
App 20220064650 - SWAYZE; Eric E. ;   et al.
2022-03-03
Compounds and methods for modulating UBE3A-ATS
Grant 11,261,446 - Jafar-nejad March 1, 2
2022-03-01
Compounds and methods for modulating C90RF72
Grant 11,260,073 - Prakash , et al. March 1, 2
2022-03-01
Compounds And Methods For Modulating Plp1
App 20220056445 - Powers; Berit Elissa
2022-02-24
Modulators Of Irf5 Expression
App 20220049248 - FREIER; Susan M.
2022-02-17
Compositions And Their Uses Directed To Huntingtin
App 20220042013 - Freier; Susan M.
2022-02-10
Modulators of IRF4 expression
Grant 11,241,451 - Zhou , et al. February 8, 2
2022-02-08
Compositions And Methods For Modulation Of Lmna Expression
App 20220031731 - Singh; Priyam ;   et al.
2022-02-03
Modulation of GYS1 expression
Grant 11,236,339 - Grossman , et al. February 1, 2
2022-02-01
Antisense compounds and uses thereof
Grant 11,236,330 - Rigo , et al. February 1, 2
2022-02-01
Selective antisense compounds and uses thereof
Grant 11,236,335 - Oestergaard , et al. February 1, 2
2022-02-01
Compounds And Methods For Reducing Prion Expression
App 20220025366 - Freier; Susan M. ;   et al.
2022-01-27
Conjugated Antisense Compounds And Their Use
App 20220023429 - Seth; Punit P. ;   et al.
2022-01-27
Oligomer-conjugate Complexes And Their Use
App 20220025370 - Prakash; Thazha P. ;   et al.
2022-01-27
Compounds and methods for reducing SNCA expression
Grant 11,230,712 - Kordasiewicz , et al. January 25, 2
2022-01-25
Modulation of angiopoietin-like 3 expression
Grant 11,225,664 - Crooke , et al. January 18, 2
2022-01-18
Compounds And Methods For Modulating Angiotensinogen Expression
App 20220000901 - Mullick; Adam ;   et al.
2022-01-06
Modulators of YAP1 expression
Grant 11,214,803 - Kim , et al. January 4, 2
2022-01-04
Compounds And Methods For Modulation Of Dystrophia Myotonica-protein Kinase (dmpk) Expression
App 20210403916 - Swayze; Eric E. ;   et al.
2021-12-30
Modulators of IRF5 expression
Grant 11,208,650 - Freier December 28, 2
2021-12-28
Compositions And Methods For Modulating Apolipoprotein C-iii Expression
App 20210395734 - Prakash; Thazha P. ;   et al.
2021-12-23
Combinations for the modulation of SMN expression
Grant 11,198,867 - Rigo , et al. December 14, 2
2021-12-14
Modulation of the notch signaling pathway for treatment of respiratory disorders
Grant 11,197,884 - Grossman December 14, 2
2021-12-14
Chirally Enriched Oligomeric Compounds
App 20210380976 - Seth; Punit P. ;   et al.
2021-12-09
Compositions for modulating expression of C9ORF72 antisense transcript
Grant 11,193,128 - Rigo December 7, 2
2021-12-07
Morpholino modified oligomeric compounds
Grant 11,180,756 - Oestergaard , et al. November 23, 2
2021-11-23
Oligonucleotide Mediated No-go Decay
App 20210355493 - Liang; Xue-hai ;   et al.
2021-11-18
Compounds And Methods For Reducing Fxi Expression
App 20210355497 - Bui; Huynh-Hoa
2021-11-18
Allele Specific Modulators Of P23h Rhodopsin
App 20210346421 - Murray; Susan F. ;   et al.
2021-11-11
GLP-1 Receptor Ligand Moiety Conjugated Oligonucleotides and Uses Thereof
App 20210346509 - Monia; Brett P. ;   et al.
2021-11-11
Methods For Reducing Lrrk2 Expression
App 20210340546 - Zhao; Hien Thuy ;   et al.
2021-11-04
Methods for modulating expression of C9ORF72 antisense transcript
Grant 11,162,096 - Bennett , et al. November 2, 2
2021-11-02
Compositions and methods for modulating Tau expression
Grant 11,155,815 - Rigo October 26, 2
2021-10-26
Modified compounds and uses thereof
Grant 11,149,264 - Seth , et al. October 19, 2
2021-10-19
Compounds and Methods for Modulation of Transcript Processing
App 20210315918 - Prakash; Thazha P. ;   et al.
2021-10-14
Methods and compositions for inhibiting PMP22 expression
Grant 11,136,577 - Hung , et al. October 5, 2
2021-10-05
Compositions and methods for modulating MECP2 expression
Grant 11,129,844 - Freier , et al. September 28, 2
2021-09-28
Modulation Of Lnc05 Expression
App 20210290653 - Yu; Allen Tingjin ;   et al.
2021-09-23
Method Of Conjugating Oligomeric Compounds
App 20210283263 - Cedillo; Isaiah E. ;   et al.
2021-09-16
Methods For Treating Hypercholesterolemia
App 20210285003 - Freier; Susan M. ;   et al.
2021-09-16
Conjugated antisense compounds and their use
Grant 11,116,843 - Seth , et al. September 14, 2
2021-09-14
Modulation of angiopoietin-like 3 expression
Grant 11,118,183 - Freier , et al. September 14, 2
2021-09-14
Compositions and Methods for Modulating PKK Expression
App 20210277401 - Prakash; Thazha P. ;   et al.
2021-09-09
Methods For Safely Reducing Thrombopoietin
App 20210275569 - Gruber; Andras ;   et al.
2021-09-09
Compounds And Methods For Modulating Ube3a-ats
App 20210277397 - Freier; Susan M. ;   et al.
2021-09-09
Compositions for modulating Ataxin 2 expression
Grant 11,111,494 - Freier September 7, 2
2021-09-07
Compounds and Methods for the Modulation of Proteins
App 20210269472 - Crooke; Stanley T. ;   et al.
2021-09-02
Oligomer-conjugate complexes and their use
Grant 11,104,899 - Prakash , et al. August 31, 2
2021-08-31
Modified Compounds and Uses Thereof
App 20210261945 - Seth; Punit P. ;   et al.
2021-08-26
Compounds And Methods For Increasing Stmn2 Expression
App 20210252039 - Bui; Huynh-Hoa ;   et al.
2021-08-19
Linkage Modified Oligomeric Compounds
App 20210254059 - Migawa; Michael T. ;   et al.
2021-08-19
Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
Grant 11,084,844 - Prakash , et al. August 10, 2
2021-08-10
Selective Antisense Compounds and Uses Thereof
App 20210238591 - Seth; Punit P. ;   et al.
2021-08-05
Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
Grant 11,078,485 - Allerson , et al. August 3, 2
2021-08-03
Compounds and methods for reducing ATXN2 expression
Grant 11,078,486 - Jafar-nejad August 3, 2
2021-08-03
Compositions for Modulating C9ORF72 Expression
App 20210230589 - Rigo; Frank
2021-07-29
Compositions and their uses directed to huntingtin
Grant 11,072,794 - Freier July 27, 2
2021-07-27
Compositions and methods for modulation of IKBKAP splicing
Grant 11,066,668 - Bennett , et al. July 20, 2
2021-07-20
Compositions For Modulating Expression Of C9orf72 Antisense Transcript
App 20210214725 - Rigo; Frank
2021-07-15
Methods of treating breast cancer
Grant 11,058,709 - Spector , et al. July 13, 2
2021-07-13
Compositions And Methods For Modulating Growth Hormone Receptor Expression
App 20210207146 - Prakash; Thazha P. ;   et al.
2021-07-08
Modulation of prekallikrein (PKK) expression
Grant 11,053,500 - Freier , et al. July 6, 2
2021-07-06
MODULATORS OF ENaC EXPRESSION
App 20210180057 - Crosby; Jeffrey R. ;   et al.
2021-06-17
Modulation of Lnc05 expression
Grant 11,033,570 - Yu , et al. June 15, 2
2021-06-15
Methods For Reducing C9orf72 Expression
App 20210169916 - Bennett; C. Frank ;   et al.
2021-06-10
Methods Of Modulating Antisense Activity
App 20210171945 - Liang; Xue-hai ;   et al.
2021-06-10
Conjugated Antisense Compounds for Use in Therapy
App 20210169917 - Viney; Nicholas J. ;   et al.
2021-06-10
Modulation Of Factor 11 Expression
App 20210169921 - Freier; Susan M. ;   et al.
2021-06-10
Compounds and methods for reducing FXI expression
Grant 11,021,710 - Bui June 1, 2
2021-06-01
Modulators Of Ezh2 Expression
App 20210155935 - Jo; Minji ;   et al.
2021-05-27
Allele specific modulators of P23H rhodopsin
Grant 11,013,758 - Murray , et al. May 25, 2
2021-05-25
Selective Antisense Compounds and Uses Thereof
App 20210147838 - Seth; Punit P. ;   et al.
2021-05-20
Oligomeric Compounds Comprising Bicyclic Nucleotides and Uses Thereof
App 20210147837 - Freier; Susan M. ;   et al.
2021-05-20
Compounds And Methods For Reducing Spdef Expression
App 20210139906 - Freier; Susan M. ;   et al.
2021-05-13
Modulation Of Huntingtin Expression
App 20210139900 - Hung; Gene ;   et al.
2021-05-13
Modulators of PCSK9 expression
Grant 11,000,595 - Swayze , et al. May 11, 2
2021-05-11
Compositions And Methods
App 20210130823 - Prakash; Thazha P. ;   et al.
2021-05-06
Methods Of Modulating Antisense Activity
App 20210130826 - OCHABA, JR.; Joseph ;   et al.
2021-05-06
Modulators Of Yap1 Expression
App 20210123059 - Kim; Youngsoo ;   et al.
2021-04-29
Modulation Of Transthyretin Expression
App 20210095281 - Monia; Brett P. ;   et al.
2021-04-01
Methods of modulating KEAP1
Grant 10,961,271 - Lee , et al. March 30, 2
2021-03-30
Modulation Of Frataxin Expression
App 20210087559 - RIGO; Frank ;   et al.
2021-03-25
Modulation Of Alpha Synuclein Expression
App 20210087562 - Freier; Susan M.
2021-03-25
Compounds And Methods For Reducing Fxi Expression
App 20210087569 - Bui; Huynh-Hoa
2021-03-25
COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN (a) EXPRESSION
App 20210087566 - PRAKASH; Thazha P. ;   et al.
2021-03-25
Compounds and methods for modulation of dystrophia myotonica-protein kinase (DMPK) expression
Grant 10,954,519 - Swayze , et al. March 23, 2
2021-03-23
Modulators Of Pnpla3 Expression
App 20210079401 - FREIER; Susan M. ;   et al.
2021-03-18
Modulators of PCSK9 Expression
App 20210077630 - Swayze; Eric E. ;   et al.
2021-03-18
Modulators of APOL1 Expression
App 20210079395 - FREIER; Susan M.
2021-03-18
Antisense Oligonucleotide Compositions
App 20210079391 - Dibble; Andrew ;   et al.
2021-03-18
Modulation of androgen receptor expression
Grant RE48,461 - Macleod , et al. March 9, 2
2021-03-09
Conjugated Antisense Compounds And Their Use
App 20210054017 - Seth; Punit P. ;   et al.
2021-02-25
Conjugated Antisense Compounds And Their Use
App 20210052631 - Prakash; Thazha P. ;   et al.
2021-02-25
Modulators of APOL1 expression
Grant 10,927,377 - Freier February 23, 2
2021-02-23
Compositions and methods for modulating apolipoprotein C-III expression
Grant 10,927,372 - Prakash , et al. February 23, 2
2021-02-23
Compounds And Methods For Modulating Gfap
App 20210038629 - Powers; Berit Elissa ;   et al.
2021-02-11
Modulators Of Irf4 Expression
App 20210038631 - Zhou; Tianyuan ;   et al.
2021-02-11
Compounds And Methods For The Modulation Of Amyloid-beta Precursor Protein
App 20210040480 - Rigo; Frank ;   et al.
2021-02-11
Compounds and methods for modulating angiotensinogen expression
Grant 10,912,792 - Mullick , et al. February 9, 2
2021-02-09
Methods for reducing LRRK2 expression
Grant 10,907,160 - Zhao , et al. February 2, 2
2021-02-02
Compositions And Methods For Modulating Ttr Expression
App 20210024923 - Prakash; Thazha P. ;   et al.
2021-01-28
Compositions And Their Uses Directed To Huntingtin
App 20210017522 - Hung; Gene ;   et al.
2021-01-21
Modified Compounds And Uses Thereof
App 20210017513 - Seth; Punit P. ;   et al.
2021-01-21
Modulation Of Hsd17b13 Expression
App 20210000906 - Murray; Susan F. ;   et al.
2021-01-07
Methods And Compositions For Modulating Apolipoprotein (a) Expression
App 20210002643 - Crooke; Rosanne M. ;   et al.
2021-01-07
Methods For Modulating Fmr1 Expression
App 20210002642 - RIGO; Frank ;   et al.
2021-01-07
Selective Antisense Compounds and Uses Thereof
App 20210002636 - Oestergaard; Michael ;   et al.
2021-01-07
Compositions and methods for modulating apolipoprotein (a) expression
Grant 10,883,104 - Prakash , et al. January 5, 2
2021-01-05
Methods Of Modulating Antisense Activity
App 20200407717 - Wang; Shiyu ;   et al.
2020-12-31
Compositions and methods for modulating angiopoietin-like 3 expression
Grant 10,875,884 - Prakash , et al. December 29, 2
2020-12-29
Oligomeric Compounds Comprising Bicyclic Nucleotides and Uses Thereof
App 20200392493 - Freier; Susan M. ;   et al.
2020-12-17
Conjugated Antisense Compounds And Their Use
App 20200392509 - Oestergaard; Michael ;   et al.
2020-12-17
Compounds And Methods For Reducing Snca Expression
App 20200392494 - Kordasiewicz; Holly ;   et al.
2020-12-17
Modulators Of Dnm2 Expression
App 20200392510 - FREIER; Susan M. ;   et al.
2020-12-17
Modulators of DNM2 expression
Grant 10,865,414 - Freier December 15, 2
2020-12-15
Oligomeric compounds comprising .alpha.-.beta.-constrained nucleic acid
Grant 10,865,413 - Oestergaard , et al. December 15, 2
2020-12-15
5' Modified Nucleosides And Oligomeric Compounds Prepared Therefrom
App 20200385722 - Prakash; Thazha P. ;   et al.
2020-12-10
Methods for treating hypercholesterolemia
Grant 10,858,657 - Freier , et al. December 8, 2
2020-12-08
Selective Reduction of Allelic Variants
App 20200377946 - Bennett; C. Frank ;   et al.
2020-12-03
Modulation of SMN expression
Grant 10,851,371 - Rigo , et al. December 1, 2
2020-12-01
Conjugated antisense compounds and their use
Grant 10,844,379 - Prakash , et al. November 24, 2
2020-11-24
Modulation of Dystrophia Myotonica-Protein Kinase (DMPK) Expression
App 20200362353 - Bennett; C. Frank ;   et al.
2020-11-19
Modulation of huntingtin expression
Grant 10,837,016 - Hung , et al. November 17, 2
2020-11-17
Compounds and methods for the modulation of proteins
Grant 10,822,369 - Crooke , et al. November 3, 2
2020-11-03
Compositions for modulating C9ORF72 expression
Grant 10,815,483 - Rigo October 27, 2
2020-10-27
Modulation of alpha synuclein expression
Grant 10,815,480 - Freier October 27, 2
2020-10-27
Compositions And Methods For Modulating Ataxin 3 Expression
App 20200325473A1 -
2020-10-15
Compositions And Their Uses Directed To Huntingtin
App 20200318116A1 -
2020-10-08
Cancer Treatment
App 20200318112A1 -
2020-10-08
Compositions for modulating expression of C9ORF72 antisense transcript
Grant 10,793,855 - Rigo October 6, 2
2020-10-06
Compositions and methods for modulating growth hormone receptor expression
Grant 10,793,862 - Prakash , et al. October 6, 2
2020-10-06
Combinations For The Modulation Of Smn Expression
App 20200308580A1 -
2020-10-01
Modulation of Factor 11 expression
Grant 10,772,906 - Freier Sept
2020-09-15
Modulators of PNPLA3 expression
Grant 10,774,333 - Freier , et al. September 15, 2
2020-09-15
Methods And Compositions For Modulating Apolipoprotein (a) Expression
App 20200276224A1 -
2020-09-03
Modulators Of Malat1 Expression
App 20200277604A1 -
2020-09-03
2'-methoxy Substituted Oligomeric Compounds And Compositions For Use In Gene Modulations
App 20200276222A1 -
2020-09-03
Antisense Compounds
App 20200276221A1 -
2020-09-03
Single-Stranded RNAI Oligonucleotides Targeting APOC-III
App 20200270609A1 -
2020-08-27
Modulation Of Huntingtin Expression
App 20200270608A1 -
2020-08-27
Glp-1 Receptor Ligand Moiety Conjugated Oligonucleotides And Uses Thereof
App 20200268898A1 -
2020-08-27
Compounds and methods for detecting oligonucleotides
Grant 10,752,940 - Greenlee , et al. A
2020-08-25
Method for synthesis of reactive conjugate clusters
Grant 10,751,419 - Migawa , et al. A
2020-08-25
Methods of predicting toxicity
Grant 10,745,756 - Burel A
2020-08-18
Compositions and their uses directed to huntingtin
Grant 10,738,307 - Hung , et al. A
2020-08-11
Morpholino Modified Oligomeric Compounds
App 20200239881A1 -
2020-07-30
Compositions For Modulating C9orf72 Expression
App 20200239882A1 -
2020-07-30
Compositions And Methods For Modulation Of Protein Aggregation
App 20200239888A1 -
2020-07-30
Compositions for Modulating Expression of C9ORF72 Antisense Transcript
App 20200239883A1 -
2020-07-30
Compositions And Methods For Modulating Hbv Expression
App 20200224198A1 -
2020-07-16
Antisense Compounds and Uses Thereof
App 20200216846A1 -
2020-07-09
Modulators Of Irf5 Expression
App 20200208147A1 -
2020-07-02
Modulators of PCSK9 Expression
App 20200197525A1 -
2020-06-25
Antisense modulation of PTP1B expression
Grant RE48,060 - Bhanot , et al.
2020-06-23
Compounds And Methods For Modulating Tmprss6 Expression
App 20200190522A1 -
2020-06-18
Modulation Of Hepatitis B Virus (hbv) Expression
App 20200190520A1 -
2020-06-18
Compositions and methods for modulating TTR expression
Grant 10,683,499 - Prakash , et al.
2020-06-16
Modulators Of Foxp3 Expression
App 20200179435A1 -
2020-06-11
5' modified nucleosides and oligomeric compounds prepared therefrom
Grant 10,676,738 - Prakash , et al.
2020-06-09
Modulation Of The Notch Signaling Pathway For Treatment Of Respiratory Disorders
App 20200171071A1 -
2020-06-04
Methods And Compositions For Modulating Alpha-1-antitrypsin Expression
App 20200157535A1 -
2020-05-21
Compositions And Methods For Enhanced Intestinal Absorption Of Conjugated Oligomeric Compounds
App 20200157548A1 -
2020-05-21
Compositions and their uses directed to huntingtin
Grant 10,655,129 - Freier
2020-05-19
Modulators Of Complement Factor B
App 20200149047A1 -
2020-05-14
Modulators Of Pnpla3 Expression
App 20200140869A1 -
2020-05-07
Compositions And Methods For Modulating Growth Hormone Receptor Expression
App 20200123551A1 -
2020-04-23
Modulation Of Angiopoietin-like 3 Expression
App 20200115711A1 -
2020-04-16
Method for solution phase detritylation of oligomeric compounds
Grant 10,618,931 - Chreng
2020-04-14
Modulation of huntingtin expression
Grant 10,619,158 - Hung , et al.
2020-04-14
Cancer treatment
Grant 10,619,157 - Crooke , et al.
2020-04-14
Modulation Of Apolipoprotein C-iii (apociii) Expression In Lipodystrophy Populations
App 20200095581A1 -
2020-03-26
Compositions For Modulating Ataxin 2 Expression
App 20200087661A1 -
2020-03-19
Compositions and methods for modulation nucleic acids through nonsense mediated decay
Grant 10,590,412 - Ward , et al.
2020-03-17
Compositions and Methods for Modulating MECP2 Expression
App 20200078389A1 -
2020-03-12
Allele Specific Modulators Of P23h Rhodopsin
App 20200069722A1 -
2020-03-05
Methods for monitoring C9ORF72 expression
Grant 10,577,604 - Bennett , et al.
2020-03-03
Modulation of DYRK1B expression
Grant 10,577,607 - Monia , et al.
2020-03-03
Conjugated antisense compounds and their use
Grant 10,570,169 - Seth , et al. Feb
2020-02-25
Selective Antisense Compounds And Uses Thereof
App 20200056187A1 -
2020-02-20
Compositions And Methods For Modulating Pkk Expression
App 20200056185A1 -
2020-02-20
Compounds And Methods For Reducing Atxn2 Expression
App 20200056179A1 -
2020-02-20
Modulation Of Apolipoprotein Ciii (apociii) Expression
App 20200056176A1 -
2020-02-20
Compositions And Methods For Modulating Complement Factor B Expression
App 20200048638A1 -
2020-02-13
Modulating apolipoprotein (a) expression
Grant 10,557,137 - Viney , et al. Feb
2020-02-11
Modulators Of Diacyglycerol Acyltransferase 2 (dgat2)
App 20200040341A1 -
2020-02-06
Compositions And Methods For Modulation Of Ikbkap Splicing
App 20200032260A1 -
2020-01-30
Compounds and methods for modulation of DUX4
Grant 10,538,763 - Rigo , et al. Ja
2020-01-21
Compositions Comprising Alternating 2'-modified Nucleosides For Use In Gene Modulation
App 20200017855A1 -
2020-01-16
Modulation Of Apolipoprotein C-iii (apociii) Expression In Lipoprotein Lipase Deficient (lpld) Populations
App 20200017854A1 -
2020-01-16
Compositions and methods for modulating Ataxin 3 expression
Grant 10,533,175 - Rigo , et al. Ja
2020-01-14
Methods for modulating Ataxin 2 expression
Grant 10,533,178 - Bennett , et al. Ja
2020-01-14
Modulation of nuclear-retained RNA
Grant 10,526,604 - Bennett , et al. J
2020-01-07
Modulation Of Factor 11 Expression
App 20200000839A1 -
2020-01-02
Modulators of SMAD7 expression
Grant 10,517,889 - Freier , et al. Dec
2019-12-31
Modulators of PCSK9 expression
Grant 10,517,953 - Swayze , et al. Dec
2019-12-31
Antisense Compounds Targeting Genes Associated With Fibronectin
App 20190382760A1 -
2019-12-19
Modified Crispr Rna And Uses Thereof
App 20190382751A1 -
2019-12-19
Compositions For Modulating C9orf72 Expression
App 20190367916A1 -
2019-12-05
Conjugated Antisense Compounds And Their Use
App 20190367914A1 -
2019-12-05
Antisense compounds
Grant 10,493,092 - Swayze De
2019-12-03
Modulation of signal transducer and activator of transcription 3 (STAT3) expression
Grant 10,479,993 - Swayze , et al. Nov
2019-11-19
Methods and compositions for modulating apolipoprotein (a) expression
Grant 10,478,448 - Crooke , et al. Nov
2019-11-19
2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations
Grant 10,478,449 - Crooke Nov
2019-11-19
Antisense compounds targeting apolipoprotein E receptor 2
Grant 10,472,634 - Rigo , et al. Nov
2019-11-12
Methods and compositions for modlating apolipoprotein (A) expression
Grant 10,472,629 - Crooke , et al. Nov
2019-11-12
Method for solution phase detritylation of oligomeric compounds
Grant 10,450,342 - Chreng , et al. Oc
2019-10-22
Compositions for modulating C9ORF72 expression
Grant 10,443,052 - Freier Oc
2019-10-15
Methods and compounds useful in conditions related to repeat expansion
Grant 10,435,430 - Prakash , et al. O
2019-10-08
Allele specific modulators of P23H rhodopsin
Grant 10,426,789 - Murray , et al. October 1, 2
2019-10-01
Compounds and methods for modulating TMPRSS6 expression
Grant 10,415,038 - Guo , et al. Sept
2019-09-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed